IP Verse

Bausch Health Ireland competitive analysis

Latest oppositions filed by Bausch Health Ireland

Explore patent oppositions filed by Bausch Health Ireland against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 16, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2959894
S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISJan 2, 2023
EP2598118
Preservative Free Bimatoprost And Timolol SolutionsALLERGANJun 4, 2019

Latest publications and patents of Bausch Health Ireland New

Explore the latest publications and patents granted to Bausch Health Ireland, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Bausch Health Ireland

Discover the latest PTAB cases involving Bausch Health Ireland, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 21, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Bausch Health Ireland

IPR2023-01114Jun 21, 2023PADAGIS ISRAEL PHARMACEUTICALSBAUSCH HEALTH IRELANDInstitution Denied
IPR2023-00016Oct 12, 2022MSN LABORATORIES PRIVATEBAUSCH HEALTH IRELANDFinal Written Decision
IPR2022-01102Jun 10, 2022MYLAN PHARMACEUTICALSBAUSCH HEALTH IRELANDInstitution Denied
IPR2022-01103Jun 10, 2022MYLAN PHARMACEUTICALSBAUSCH HEALTH IRELANDInstitution Denied
IPR2022-01104Jun 10, 2022MYLAN PHARMACEUTICALSBAUSCH HEALTH IRELANDInstitution Denied
IPR2022-01105Jun 10, 2022MYLAN PHARMACEUTICALSBAUSCH HEALTH IRELANDInstitution Denied
IPR2022-00722Mar 21, 2022MYLAN PHARMACEUTICALSBAUSCH HEALTH IRELANDFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Bausch Health Ireland with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 16, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BAUSCH HEALTH IRELAND2 - - 7
ALLERGAN11281333
MSN LABORATORIES PRIVATE - 11 -
MYLAN PHARMACEUTICALS - - 94 -